Drug Trial Radar · NCT02515318
Physiotherapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Last checked: Nov 20, 2026Latest source record: Jul 13, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
60
Planned (sponsor's estimate)
Start
Sep 2015
Primary completion
Mar 2017
Study completion Jul 2018
Sponsor
- Lead sponsor
- Universidad de GranadaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 4, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Single group
- Masking
- Single (investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Chronic Obstructive Pulmonary Disease (COPD) is projected to be the fifth leading burden of disease worldwide by the year 2020. An acute exacerbation of COPD (AECOPD) is defined as an acute event characterized by a worsening of the patient's respiratory symptoms that requires a modification in the medication. AECOPD are frequent (mean of 1-4 exacerbations each year). It increases in frequency with the severity of the disease. The objective of this study is to examine whether a physical therapy intervention can reduce impairment in patients with COPD during hospitalization due to an acute exacerbation.
Conditions
- COPD
Interventions
Physiotherapy programOther
The physiotherapy treatment will be performed during the hospitalization, every day during 45-60 minutes, and included: breathing exercises, electrostimulation in quadriceps with voluntary contraction and exercises with theraband.
Medical standard treatmentDrug
The standard medical treatment consists on: Inhaled bronchodilators: Short acting inhaled β2 agonists ( salbutamol and terbutaline) and anticholinergic agents (ipratropium and oxitropium bromide). Glucocorticoids: Inhaled glucocorticoids including beclomethasone dipropionate, budesonide, flunisolide, fluticasone propionate and triamcinolone acetonide, depending on the expert criteria. \- Antibiotics: The antibiotics were administered according to the GOLD criteria including the β-lactamase inhibitor and fluoroquinolones.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Muscle strengthTime frame: Participants will be followed for the duration of hospital stay, an expected average of 9 days.
- Exercise capacityTime frame: Participants will be followed for the duration of hospital stay, an expected average of 9 days.
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
University of Granada
Granada, Spain · Recruiting
Department of Physical Therapy
Granada, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.